- Home
- ASST vs EBS Comparison
ASST vs EBS Comparison
Compare ASST & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASST | EBS |
|---|---|---|
| Founded | 2020 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 636.4M | 663.3M |
| IPO Year | 2023 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ASST | EBS |
|---|---|---|
| Price | $1.04 | $13.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.50 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 75.2M | 788.6K |
| Earning Date | 11-14-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | $5,512,106.00 | ★ $788,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.21 |
| P/E Ratio | ★ N/A | $9.51 |
| Revenue Growth | ★ 125.01 | N/A |
| 52 Week Low | $0.73 | $4.02 |
| 52 Week High | $7.89 | $13.41 |
Technical Indicators
Market Signals| Indicator | ASST | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 55.15 | 67.74 |
| Support Level | $0.73 | $12.02 |
| Resistance Level | $0.87 | $12.90 |
| Average True Range (ATR) | 0.08 | 0.50 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 84.76 | 75.00 |
Price Performance
Historical ComparisonAbout ASST Asset Entities Inc. Class B
Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.